Showing results (31-40 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|January 1, 1986
The dexamethasone suppression test (DST) in predicting response to desipramine and amitriptyline in depressed outpatientsE D Peselow, N Goldring, M Stanley, et al.International Clinical Psychopharmacology|October 1, 1986
Fluoxetine response: endpoint vs pattern analysisR R Fieve, P J Goodnick, E Peselow, et al.International Clinical Psychopharmacology|July 1, 1986
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patientsB WistedtInternational Clinical Psychopharmacology|March 15, 2019
Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophreniaNobuhisa Kanahara, Kensuke Yoshimura, Miwako Nakamura, et al.International Clinical Psychopharmacology|July 1, 1988
Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approachA Bertolino, D Crippa, S di Dio, et al.International Clinical Psychopharmacology|January 25, 2021
Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychoticsNozomi Nakajima, Nao Mizoe, Fuminari Misawa, et al.International Clinical Psychopharmacology|January 25, 2021
Benefit of long-acting paliperidone in Huntington's disease: a case reportHervé Javelot, Mylène Meyer, Solène Frismand, et al.International Clinical Psychopharmacology|January 1, 1988
A study of buspirone coprescribed with histamine H2-receptor antagonists in anxious outpatientsS Levine, M J NapolielloInternational Clinical Psychopharmacology|March 3, 2017
Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFYSteven G Potkin, Jean-Yves Loze, Carlos Forray, et al.International Clinical Psychopharmacology|December 17, 2004
The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary studyRuth Gross-Isseroff, Ayelet Magen, Roni Shiloh, et al.Pageof 212